Notes
see PharmacoEconomics & Outcomes News 813 p1; 803348064
Reference
Cohen D. Bayer and Novartis appeal ruling that Avastin for wet AMD is lawful. BMJ 2018: k4586, No. 363, 30 Oct 2018. Available from: URL: https://doi.org/10.1136/bmj.k4586
Rights and permissions
About this article
Cite this article
Companies plan to appeal ruling on bevacizumab for wet AMD. PharmacoEcon Outcomes News 815, 1 (2018). https://doi.org/10.1007/s40274-018-5382-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5382-4